Ipatimup

RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH

Venceslau Hespanhol

Name: Venceslau Hespanhol

E-mail: vespanhol@ipatimup.pt

Venceslau Hespanhol

Member of

Researcher of Intercellular Communication and Cancer

Short CV

Venceslau José Coelho Pinto Hespanhol, was born on June 5, 1957, graduated in Medicine 1981, Specialization in Pulmonology 1991, Doctorate in Medicine in 1999, Aggregation to Faculdade Medicina do Porto 2004, Head of The Pulmonology Service Centro Hospitalar e Universitário S. João (CHUSJ) from 2005 to 2009, Director of UAG Medicine CHUSJ 2007-2009; Director of UAG MCDT 2009-2012, Clinical Director of CHUSJ in 2010; Director of the Pulmonology Service at Centro Hospitalar e Universitário S. João since 2019; Full Professor of Pulmonology, Invited since 2020. Co-Regent of the Discipline of Pulmonology of the Integrated Masters in Medicine, Faculty of Medicine, University of Porto. Specialization in Interventional Pulmonology, Thoracic Oncology, Epidemiology and Biostatistics. 105 publications in journals with impact factor, index h-19; index i - 36

Senior Author

1. Freitas C, Sousa C, Machado F, Serino M, Santos V, Cruz-Martins N, Teixeira A, Cunha A, Pereira T, Oliveira HP, Costa JL, Hespanhol V

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer. Frontiers in oncology 11: 634316, 2021. [Review]

doi: 10.3389/fonc.2021.634316 PMID: 33937034.

6.2 (*)

2. Fernandes MGO, Sousa C, Pereira Reis J, Cruz-Martins N, Souto Moura C, Guimarães S, Justino A, Pina MJ, Magalhães A, Queiroga H, Marques JA, Machado JC, Costa JL, Hespanhol V

Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic. Cells 10: ., 2021. [Article]

doi: 10.3390/cells10081912 PMID: 34440680.

6.6 (*)

3. Fernandes MGO, Cruz-Martins N, Machado JC, Costa JL, Hespanhol V

The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management. Cancer cell international 21: 675, 2021. [Review]

doi: 10.1186/s12935-021-02382-0 PMID: 34915883.

5.7 (*)

4. Fernandes MGO, Sousa C, Jacob M, Almeida L, Santos V, Araújo D, Novais Bastos H, Magalhães A, Cirnes L, Moura CS, Queiroga H, Cruz-Martins N, Hespanhol V

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer. Frontiers in oncology 11: 602924, 2021. [Article]

doi: 10.3389/fonc.2021.602924 PMID: 34026599.

6.2 (*)

@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto